McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale
Executive Summary
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said
You may also be interested in...
Payers Having More Impact On R&D, Pfizer Says; Asenapine Is Early Casualty
Pfizer's termination of its codevelopment agreement with Organon for the antipsychotic asenapine is indicative of the increasingly important role payer considerations play in development decisions, Pfizer CEO Jeffrey Kindler said
Payers Having More Impact On R&D, Pfizer Says; Asenapine Is Early Casualty
Pfizer's termination of its codevelopment agreement with Organon for the antipsychotic asenapine is indicative of the increasingly important role payer considerations play in development decisions, Pfizer CEO Jeffrey Kindler said
Pfizer Cost-Cutting: Details Are Sketchy, But Sales Force Is On The Table
Pfizer CEO Jeffrey Kindler has opened the door to sales force reductions as part of the firm's latest cost-cutting initiative, announced Oct. 1